AbbVie Inc. closed 5.34% below its 52-week high of $207.32, which the company reached on October 31st.
Insider Monkey on MSN8d
AbbVie Inc. (ABBV): Among Lee Munder Capital Group’s Top Stock Pickswe are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against the other stocks. Lee Munder Capital Group ...
24/7 Wall St. on MSN7d
AbbVie Just Paid Investors: Here's How Much They ReceivedAbbVie just rewarded its shareholders again with a dividend. This stock has boosted its payout annually for more than 50 ...
Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for ...
DCF analysis, a reliable and data-driven approach to estimating its intrinsic value. Instead of using future free cash flow ...
AbbVie Inc. offers a combination of rock-solid business mix, aggressive growth strategy, and shareholder-friendly capital allocation. The company holds strong positions in rapidly growing markets ...
AbbVie Inc. (NYSE: ABBV) is rewarding its shareholders once again with a quarterly dividend of $1.64, payable on Friday, Feb. 14. That is almost 6% higher than the prior payout. The company ...
AbbVie Inc. (NYSE:ABBV) is a research-based pharmaceutical company that develops and sells products to treat chronic diseases in oncology, gastroenterology, rheumatology, dermatology, virology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback